QRS and QTc interval prolongation in the prediction of long-term mortality of patients with acute destabilised heart failure

Heart

Volumn 93, Issue 9, 2007, Pages 1093-1097

  Breidthardt, Tobias ^a   Christ, Michael ^a   Matti, Miriam ^a   Schrafl, Delia ^a   Laule, Kirsten ^a   Noveanu, Markus ^a   Boldanova, Tujana ^a   Klima, Theresia ^a   Hochholzer, Willibald ^a   Perruchoud, André P ^a   Mueller, Christian ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

AGED; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MORTALITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; QRS COMPLEX; QT PROLONGATION;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ARRHYTHMIA; ELECTROCARDIOGRAPHY; EMERGENCY SERVICE, HOSPITAL; EPIDEMIOLOGIC METHODS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED; PROGNOSIS;

EID: 34548169604     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2006.102319     Document Type: Article

References (28)

1. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force On Practice Guidelines. Circulation 2001;104:2996-3007.
2. Task Force for the Diagnosis And Treatment Of Chronic Heart Failure, European Society of Cardiology: W. J. Remme and K. Swedberg. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527-60.
3. The Task Force on Acute Heart Failure of the European Society of Cardiology. Nieminen MS, Böhm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. Eur Heart J 2005;26:384-416.
4. Cleland JG, Swedberg K, Follath F, et al. Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart failure survey programme - a survey on the quality of care among patients with heart failure in Europe.Part 1: patient characteristics and diagnosis. Eur Heart J 2003;24:442-63.
5. Aaronson KD, Schwartz JS, Chen TM, et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997;95:2660-7.
6. Xiao HB, Roy C, Fujimoto S, et al. Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy. Int J Cardiol 1996;53:163-70.
7. Bruch C, Gotzmann M, Stypmann J, et al. Electrocardiography and Doppler echocardiography for risk stratification in patients with chronic heart failure: incrementarprognostic value of QRS duration and a restrictive mitral filling pattern. J Am Coll Cardiol 2005;45:1072-5.
8. Bode-Schnurbus L, Backer D, Block M, et al. QRS duration: a simple marker for predicting cardiac mortality in ICD patients with heart failure. Heart 2003;89:1157-62.
9. Freudenberger R, Sikora JA, Fisher M, et al. Electrocardiogram and clinical characteristics of patients referred for cardiac transplantation: implications for pacing in heart failure. Clin Cardiol 2004;27:151-3.
10. Vrtovec B, Delgado R, Zewail A, et al. Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure. Circulation 2003;107: 1764-9.
11. Mueller C, Scholer A, Laule Kilian K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004;350:647-54.
12. Josephson ME. Clinical cardiac electrophysiology: techniques and interpretations, 3rd edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2002.
13. Toivonen L. More light on QT interval measurement. Heart 2002;87:193-4.
14. Follath F, Cleland JG, Just H, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial, iancef 2002;360:196-202.
15. Lepore JJ, Maroo A, Bigatello IM, et al. Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension. Chest 2005;127:1647-53.
16. Bristow MR, Saxon LA, Boehmer J, et al. The Comparison of Medical Therapy, pacing and Defibrillation in Heart Failure Investigators. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
17. Kass DA, Chen CH, Curry C, et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 1999;99:1567-73.
18. Sweeney MO, Hellkamp AS, Lee KL, Lamas GA, for the Mode Selection Trial (MOST) Investigators. Association of prolonged QRS duration with death in a clinical trail of pacemaker therapy for sinus node dysfunction. Circulation 2005;111:2418-23.
19. Bramlet DA, Morris KG, Coleman RE, et al. Effect of rate-dependent left bundle branch block on global and regional left ventricular function. Circulation 1983;67:1059-65.
20. Bauer A, Watanabe MA, Barthel P, et al. QRS duration and late mortality in unselected post-infarction patients of the revascularization era. Eur Heart J 2006;27:427-33.
21. Schouten EG, Dekker JM, Meppelink P, et al. QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation 1991;84:1516-23.
22. Peters RW, Byington RP, Barker A, et al. Prognostic value of prolonged ventricular repolarization following myocardial infarction: the BHAT experience: the BHAT Study Group. J Clin Epidemiol 1990;43:167-72.
23. Rossing P, Breum L, Major-Pedersen A, et al. Prolonged QTc interval predicts mortality in patients with type I diabetes mellitus. Diabet Med 2001;18:199-205.
24. Brendorp B, Elming H, Jun L, et al. QTc interval as a guide to select those patients with congestive heart failure and reduced left ventricular systolic function who will benefit from antiarrhythmic treatment with defetilide. Circulation 2001;103:1422-7.
25. Spargias KS, Lindsay SJ, Kawar GL, et al. QT dispersion as apredictor of long-term mortality in patients with acute myocardial infarction and clinical evidence of heart failure. Eur Heart J 1999;20:1158- 65.
26. Brooksy P, Batin PD, Nolan J, et al. The relationship between QT intervals and mortality in ambulant patients with chronic heart failure: the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-HEART). Eur Heart J 1999;20:1335-41.
27. Anastasiou-Nana MI, Nonas JN, Karagounis LA, et al. Relation of dispersion of QRS and QT in patients with advanced congestive heart failure to cardiac and sudden death mortality. Am J Cardiol 2000;85:1212-17.
28. Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction. Comparison with Doppler velocity recordings. Circulation 2002;105:595-601.